Department of Experimental and Clinical Medicine - Section of Anatomy and Histology, University of Florence, Largo Brambilla 3, 50134, Florence, Italy.
Cell Tissue Res. 2018 Jun;372(3):549-570. doi: 10.1007/s00441-018-2792-3. Epub 2018 Feb 5.
Satellite cell-mediated skeletal muscle repair/regeneration is compromised in cases of extended damage. Bone marrow mesenchymal stromal cells (BM-MSCs) hold promise for muscle healing but some criticisms hamper their clinical application, including the need to avoid animal serum contamination for expansion and the scarce survival after transplant. In this context, platelet-rich plasma (PRP) could offer advantages. Here, we compare the effects of PRP or standard culture media on C2C12 myoblast, satellite cell and BM-MSC viability, survival, proliferation and myogenic differentiation and evaluate PRP/BM-MSC combination effects in promoting myogenic differentiation. PRP induced an increase of mitochondrial activity and Ki67 expression comparable or even greater than that elicited by standard media and promoted AKT signaling activation in myoblasts and BM-MSCs and Notch-1 pathway activation in BM-MSCs. It stimulated MyoD, myogenin, α-sarcomeric actin and MMP-2 expression in myoblasts and satellite cell activation. Notably, PRP/BM-MSC combination was more effective than PRP alone. We found that BM-MSCs influenced myoblast responses through a paracrine activation of AKT signaling, contributing to shed light on BM-MSC action mechanisms. Our results suggest that PRP represents a good serum substitute for BM-MSC manipulation in vitro and could be beneficial towards transplanted cells in vivo. Moreover, it might influence muscle resident progenitors' fate, thus favoring the endogenous repair/regeneration mechanisms. Finally, within the limitations of an in vitro experimentation, this study provides an experimental background for considering the PRP/BM-MSC combination as a potential therapeutic tool for skeletal muscle damage, combining the beneficial effects of BM-MSCs and PRP on muscle tissue, while potentiating BM-MSC functionality.
卫星细胞介导的骨骼肌修复/再生在损伤持续存在的情况下会受到损害。骨髓间充质基质细胞(BM-MSCs)有希望用于肌肉愈合,但一些批评意见阻碍了它们的临床应用,包括需要避免动物血清污染进行扩增和移植后存活率低。在这种情况下,富含血小板的血浆(PRP)可能具有优势。在这里,我们比较了 PRP 或标准培养基对 C2C12 成肌细胞、卫星细胞和 BM-MSC 活力、存活、增殖和肌生成分化的影响,并评估了 PRP/BM-MSC 组合在促进肌生成分化方面的效果。PRP 诱导的线粒体活性和 Ki67 表达的增加与标准培养基相当,甚至更大,促进了成肌细胞和 BM-MSCs 中的 AKT 信号激活和 BM-MSCs 中的 Notch-1 通路激活。它刺激了 C2C12 成肌细胞和卫星细胞中的 MyoD、myogenin、α-横纹肌肌动蛋白和 MMP-2 的表达以及卫星细胞的激活。值得注意的是,PRP/BM-MSC 组合比单独的 PRP 更有效。我们发现,BM-MSCs 通过 AKT 信号的旁分泌激活影响成肌细胞的反应,有助于阐明 BM-MSC 作用机制。我们的结果表明,PRP 是体外 BM-MSC 操作的良好血清替代品,可能对体内移植细胞有益。此外,它可能会影响肌肉固有祖细胞的命运,从而有利于内源性修复/再生机制。最后,在体外实验的限制内,本研究为考虑 PRP/BM-MSC 组合作为骨骼肌损伤的潜在治疗工具提供了实验背景,该组合结合了 BM-MSCs 和 PRP 对肌肉组织的有益作用,同时增强了 BM-MSC 的功能。